simvastatin has been researched along with Staphylococcal Skin Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dix, BR; Hughes, JD; Ko, HHT; Lareu, RR | 1 |
| Abushahba, MF; Hamed, MI; Hedrick, VE; Mohammad, H; Paul, LN; Seleem, MN; Sobreira, TJ; Thangamani, S | 1 |
2 other study(ies) available for simvastatin and Staphylococcal Skin Infections
| Article | Year |
|---|---|
In vitro antibacterial effects of statins against bacterial pathogens causing skin infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Discovery; Drug Repositioning; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Simvastatin; Skin; Staphylococcal Skin Infections; Staphylococcus aureus | 2018 |
Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Biofilms; Cytokines; Disease Models, Animal; Drug Synergism; Female; Gram-Negative Bacteria; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation Mediators; Metabolic Networks and Pathways; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Proteolysis; Simvastatin; Staphylococcal Skin Infections; Staphylococcus | 2015 |